RxDoctor Payments Data

Mary Dixon, PA

Medical · Brunswick, GANPI 1710640669

Payments from drug & device makers

$3,403in general payments, 2019–2025

Across 188 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$365
  • AstraZeneca$332
  • Bayer$278
  • Amgen$246
  • AbbVie$198
  • Boston Scientific$169
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$3,403100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,403 in reported general payments places this provider in the 75th percentile of 950 medical providers in Georgia.

See all medical providers in Georgia

Medicare billing

Part B allowed, 2024
$49,762
Medicare patients
182
Services billed
643

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide110$129,923
OzempicSemaglutide48$56,702
JardianceEmpagliflozin24$23,798
MyrbetriqMirabegron29$20,925
RybelsusSemaglutide11$20,845
EliquisApixaban19$19,278
FarxigaDapagliflozin Propanediol19$18,529
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$10,783
GemtesaVibegron13$10,286
JanumetSitagliptin Phos/Metformin Hcl13$9,797
Lantus SolostarInsulin Glargine,hum.Rec.Anlog35$3,741
Dexlansoprazole DrDexlansoprazole13$2,628
SynthroidLevothyroxine Sodium22$1,964
Levothyroxine Sodium175$1,788
Albuterol Sulfate HfaAlbuterol Sulfate66$1,758

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$116$129,923110 claims
Novo NordiskOzempic, Rybelsus$365$77,54759 claims
AstraZenecaFarxiga, Breztri Aerosphere$332$29,31230 claims
Boehringer IngelheimJardiance$145$23,79824 claims
Astellas Pharma US IncMyrbetriq$56$20,92529 claims
PfizerEliquis$168$19,27819 claims
MerckJanumet$43$9,79713 claims
AbbVieSynthroid$198$1,96422 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 950 medical providers in Georgia.

Other medical in Brunswick

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →